Accumulation of liposomes in metastatic tumor sites is not necessary for anti-cancer drug efficacy

Abstract Background The tumor microenvironment is profoundly heterogeneous particularly when comparing sites of metastases. Establishing the extent of this heterogeneity may provide guidance on how best to design lipid-based drug delivery systems to treat metastatic disease. Building on our previous...

Full description

Bibliographic Details
Published in:	Journal of Translational Medicine
Main Authors:	Jessica Kalra, Jennifer Baker, XuXin Sun, Alastair Kyle, Andrew Minchinton, Marcel B. Bally
Format:	Article
Language:	English
Published:	BMC 2024-07-01
Subjects:	Liposomes Enhanced permeability and retention effect Metastases/metastasis Tumor microenvironment Inter- and intra-tumor heterogeneity Pre-clinical models
Online Access:	https://doi.org/10.1186/s12967-024-05428-9

Similar Items

Breast Cancer Heterogeneity
by: Caterina Fumagalli, et al.
Published: (2021-08-01)

Targeting the Tumor Microenvironment with Fluorescence-Activatable Bispecific Endoglin/Fibroblast Activation Protein Targeting Liposomes
by: Felista L. Tansi, et al.
Published: (2020-04-01)

Understanding the heterogeneity of pancreatic ductal adenocarcinoma
by: Juan Iovanna, et al.
Published: (2025-10-01)

Immune dynamics shaping pre-metastatic and metastatic niches in liver metastases: from molecular mechanisms to therapeutic strategies
by: Chang Zhu, et al.
Published: (2024-11-01)

When Albumin Meets Liposomes: A Feasible Drug Carrier for Biomedical Applications
by: Kazuaki Taguchi, et al.
Published: (2021-03-01)

Induction of therapeutic immunity and cancer eradication through biofunctionalized liposome-like nanovesicles derived from irradiated-cancer cells
by: Suke Deng, et al.
Published: (2024-04-01)

Single-cell RNA sequencing reveals the intra-tumoral heterogeneity and immune microenvironment of small cell carcinoma of the ovary, hypercalcemic type
by: Yi Gao, et al.
Published: (2025-04-01)

Enhancing targeted delivery and efficacy of PEGylated liposomal doxorubicin with liposomal minoxidil: comprehensive in silico, in vitro, and in vivo tumor model studies
by: Vahideh Mohammadzadeh, et al.
Published: (2025-12-01)

Intra-tumor heterogeneity-resistant gene signature predicts prognosis and immune infiltration in breast cancer
by: Haixing Shen, et al.
Published: (2025-09-01)

The effectiveness of liposomal doxorubicin hydrochloride in combination with cyclophosphan in the treatment of breast cancer in an experiment
by: L. A. Balykova, et al.
Published: (2021-12-01)

Recent advances in nanomedicine preparative methods and their therapeutic potential for colorectal cancer: a critical review
by: Arinjay Jain, et al.
Published: (2023-06-01)

Single-cell transcriptomics reveals tumor microenvironment remodeling in hepatocellular carcinoma with varying tumor subclonal complexity
by: Jian Shi, et al.
Published: (2024-08-01)

The immune cell landscape of glioblastoma patients highlights a myeloid-enriched and immune suppressed microenvironment compared to metastatic brain tumors
by: Beatrice Musca, et al.
Published: (2023-10-01)

Tumor microenvironment and exosomes in brain metastasis: Molecular mechanisms and clinical application
by: Yirizhati Aili, et al.
Published: (2022-10-01)

Design and Application of pH-Responsive Liposomes for Site-Specific Delivery of Cytotoxin from Cobra Venom
by: Lin Q, et al.
Published: (2024-06-01)

Paclitaxel-loaded ginsenoside Rg3 liposomes for drug-resistant cancer therapy by dual targeting of the tumor microenvironment and cancer cells
by: Ying Zhu, et al.
Published: (2023-07-01)

Integrative radiomics of intra- and peri-tumoral features for enhanced risk prediction in thymic tumors: a multimodal analysis of tumor microenvironment contributions
by: Liang zhu, et al.
Published: (2025-07-01)

Application of Spatial Transcriptomics in Digestive System Tumors
by: Bowen Huang, et al.
Published: (2024-12-01)

Tumor microenvironment differences between primary tumor and brain metastases
by: Bernardo Cacho-Díaz, et al.
Published: (2020-01-01)

Breaking the heterogeneity barrier: a robust prognostic signature for survival stratification and immune profiling in triple-negative breast cancer
by: Haixing Shen, et al.
Published: (2025-09-01)

Novel multi-omics analysis revealing metabolic heterogeneity of breast cancer cell and subsequent development of associated prognostic signature
by: Peng Zhang, et al.
Published: (2025-09-01)

The Role of Mesenchymal Reprogramming in Malignant Clonal Evolution and Intra-Tumoral Heterogeneity in Glioblastoma
by: Qiong Wu, et al.
Published: (2024-05-01)

Regulating Intratumoral Fungi With Hydrogels: A Novel Approach to Modulating the Tumor Microbiome for Cancer Therapy
by: Ping Chen, et al.
Published: (2025-05-01)

Liposomal formulations of carboplatin injected by convection-enhanced delivery increases the median survival time of F98 glioma bearing rats
by: Minghan Shi, et al.
Published: (2018-10-01)

Biomimetic on-chip assay reveals the anti-metastatic potential of a novel thienopyrimidine compound in triple-negative breast cancer cell lines
by: Indira Sigdel, et al.
Published: (2023-09-01)

Enhancing in Vitro anti-metastatic efficacy and deep penetration into tumor spheroid of docetaxel-loaded liposomes via size optimization for prostate cancer treatment
by: Saksorn Klibaim, et al.
Published: (2025-03-01)

Enhanced Corneal Permeation of Pilocarpine Using Liposome Technology
by: Eskandar Moghimipour, et al.
Published: (2021-09-01)

Dectin-1-targeted pH-responsive liposomal nanoplatform delivering Plantago Asiatica L. acidic polysaccharide for immunomodulation and immunosuppressive breast cancer microenvironment reprogramming
by: Wanbing Pan, et al.
Published: (2025-09-01)

Tumor heterogeneity: preclinical models, emerging technologies, and future applications
by: Marco Proietto, et al.
Published: (2023-04-01)

Innovative approach to the detection of circulating tumor biomarkers: multi-dimensional application of liposome technology
by: Weichu Tan, et al.
Published: (2025-04-01)

In vivo mechanisms of resveratrol liposomes in targeting the TLR4/NLRP3 pathway in lung cancer
by: Chunxia Chen, et al.
Published: (2025-08-01)

Preparation and in vitro evaluation of hemoglobin-paclitaxel dual loaded liposomes for improving tumor hypoxia resistance
by: Xunyi YOU, et al.
Published: (2024-03-01)

Engineering neuroblastoma models for clinical translation
by: Taiyu Song, et al.
Published: (2025-01-01)

Integrative single-cell transcriptomic analyses reveal the cellular ontological and functional heterogeneities of primary and metastatic liver tumors
by: Menghui Gui, et al.
Published: (2024-02-01)

Aptamer-functionalized liposomes for drug delivery
by: Ka-Ying Wong, et al.
Published: (2024-08-01)

Celastrol-loaded ginsenoside Rg3 liposomes boost immunotherapy by remodeling obesity-related immunosuppressive tumor microenvironment in melanoma
by: Hongyan Zhang, et al.
Published: (2025-05-01)

Rapid Target Binding and Cargo Release of Activatable Liposomes Bearing HER2 and FAP Single-Chain Antibody Fragments Reveal Potentials for Image-Guided Delivery to Tumors
by: Felista L. Tansi, et al.
Published: (2020-10-01)

Cyclodextrins permeabilize DPPC liposome membranes: a focus on cholesterol content, cyclodextrin type, and concentration
by: Ghenwa Nasr, et al.
Published: (2023-10-01)

Cuproptosis engages in c-Myc-mediated breast cancer stemness
by: Runtian Wang, et al.
Published: (2023-06-01)

The Identification of Novel Prognostic and Predictive Biomarkers in Breast Cancer via the Elucidation of Tumor Ecotypes Using Ecotyper
by: Feng Du, et al.
Published: (2025-08-01)